About company
Collaborative Medicinal Development is a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases. The Company's lead drug, CuATSM, was licensed from the University of Melbourne and entered clinical trials in ALS and Parkinson's disease in 2017.
- Unknown
- ClinicalOperations@ColMedDev.com
- Unknown
- colmeddev.com/
- Not verified company
